QRxPharma Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Bedminster NJ United States (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2007
NCT00565760
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

morphine (7 trials)

oxycodone (oxycontin) (5 trials)

Drugs in Phase 2 Trials (1)

acetaminophen (tylenol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pain, Postoperative (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 3